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Abstract
Myocardial contractility depends on several mechanisms such as
coronary perfusion pressure (CPP) and flow as well as on α1-adreno-
ceptor stimulation. Both effects occur during the sympathetic stimula-
tion mediated by norepinephrine. Norepinephrine increases force
development in the heart and produces vasoconstriction increasing
arterial pressure and, in turn, CPP. The contribution of each of these
factors to the increase in myocardial performance needs to be clarified.
Thus, in the present study we used two protocols: in the first we
measured mean arterial pressure, left ventricular pressure and rate of
rise of left ventricular pressure development in anesthetized rats
 (N = 10) submitted to phenylephrine (PE) stimulation before and after
propranolol plus atropine treatment. These observations showed that
in vivo α1-adrenergic stimulation increases left ventricular-developed
pressure (P<0.05) together with arterial blood pressure (P<0.05). In
the second protocol, we measured left ventricular isovolumic systolic
pressure (ISP) and CPP in Langendorff constant flow-perfused hearts.
The hearts (N = 7) were perfused with increasing flow rates under
control conditions and PE or PE + nitroprusside (NP). Both CPP and
ISP increased (P<0.01) as a function of flow. CPP changes were not
affected by drug treatment but ISP increased (P<0.01). The largest ISP
increase was obtained with PE + NP treatment (P<0.01). The results
suggest that both mechanisms, i.e., direct stimulation of myocardial
α1-adrenoceptors and increased flow, increased cardiac performance
acting simultaneously and synergistically.
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Introduction
Myocardial contractility depends on sev-
eral mechanisms including the increase of
coronary perfusion pressure (CPP) and flow
as well as autonomic nervous system stimu-
lation. Increases of coronary flow (1-3) and
perfusion pressure (4-7) are reported to in-
crease myocardial contractility. Also, in-
creased sympathetic activity enhances con-
tractility, activating ß1 and α1-adrenocep-
tors. ß1-adrenoceptor stimulation is known
to increase heart rate and contractility acting
on G-proteins and increasing intracellular
cAMP concentration (8). Stimulation of α1-
adrenoceptors increases force development
in the myocardium acting on G-proteins and
inducing phospholipase C activation (9-13).
At the same time the action on vascular
smooth muscle (VSM) produces peripheral
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vasoconstriction that increases arterial pres-
sure and, consequently, the coronary perfu-
sion pressure and flow (3). All these effects
may occur simultaneously during sympa-
thetic stimulation produced by the effects of
norepinephrine on the heart and on the VSM
of the arterial systemic circulation.
However, it is not known whether direct
action on the myocardium or the increase in
coronary perfusion pressure and flow contri-
butes more to the increase in myocardial
contraction that occurs during α1-sympa-
thetic stimulation. To elucidate this point,
the effects of α1-adrenoceptor stimulation
were studied in anesthetized rats and in rat
hearts perfused with increasing flow rates.
Material and Methods
Care and use of laboratory animals were
according to NIH guidelines. All rats had
free access to water and were fed with rat
chow ad libitum.
Male Wistar rats (EPM strain) weighing
250 to 350 g (N = 17) were divided into two
groups. In the first group (N = 10), the rats
were anesthetized ip with urethane (1.8 g/
kg) and the right carotid artery and jugular
vein were cannulated. Urethane was supple-
mented (0.45 g/kg) when rats showed tach-
ypnea plus movement of mystacial vibris-
sae. The anesthetized rats were allowed to
breathe room air spontaneously. A PE50
cannula was introduced through the carotid
artery into the left ventricle (LV). Left ven-
tricular systolic pressure (LVSP) and its peak
first time derivative (dP/dtmax) were meas-
ured using a pressure transducer (Gold
P23XL) connected to an amplifier (MP100-
FUNBEC) and recorded with a Nihon-
Kohden (RM-6000) polygraph. Mean arteri-
al pressure (MAP) was recorded at the femo-
ral artery level and the ECG was recorded
with a bioelectric amplifier (ME 100
FUNBEC) as carried out for people. A venous
cannula in the jugular vein was used for drug
infusion.
In the second group (N = 7), animals
were injected with heparin (50 IU) and killed
10 min later by cervical dislocation. The
heart was rapidly removed, transferred to a
Langendorff apparatus and perfused through
the aortic stump under a constant flow (10
ml/min) which was changed when necessary
at a temperature of 31oC. The composition
of the nutrient solution was: 120 mM NaCl,
5.4 mM KCl, 1.0 mM MgCl2, 1.25 mM
CaCl2, 27 mM NaHCO3, 2.0 mM NaH2PO4,
1.2 mM  Na2SO4, and 11.0 mM glucose. The
solution was previously filtered with a 0.8-
µm Millipore filter and continuously gassed
with 95% O2 + 5% CO2 mixture (pH = 7.3-
7.4). The right atrium was excised and paced
at 200 beats/min. The left atrium was then
opened to introduce a soft distensible bal-
loon mounted at the tip of a rigid plastic tube
into the left ventricular cavity through the
atrioventricular valve. To avoid liquid accu-
mulation in the ventricular cavity, the ven-
tricle was perforated with a puncture needle.
The balloon was connected to a pressure
transducer (Gould P23XL) and to a syringe
via a Y piece, so that the diastolic pressure of
the LV could be adjusted to predetermined
values by injecting water into the balloon.
Developed isovolumic systolic pressure (ISP)
was measured with a chart recorder
(FUNBEC RG300). CPP was also measured
at the aortic cannula level. Measurements
were initiated after a period of stabilization
of 30 min with the heart driven at 200 beats/
min.
Experimental protocols
Anesthetized rats
After cannulation of the LV the effects of
iv bolus injections of 10 ng phenylephrine
(PE) on LVSP and its dP/dt were deter-
mined. To avoid the interference of regula-
tory autonomic reflexes the protocol was
repeated before and after ß-adrenergic plus
cholinergic blockade with propranolol (3 mg/
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kg) plus atropine sulfate (1 mg/kg) treat-
ment. Mean blood pressure was measured
simultaneously.
Langendorff-perfused hearts
The basic protocol was performed begin-
ning with a constant diastolic pressure of 4 to
7 mmHg by adjusting the volume of the
balloon. During the experiments the volume
of the balloon was kept constant, thus per-
mitting the measurement of the diastolic and
systolic pressure changes produced by each
perfusion flow with nutrient solution alone
or containing PE or nitroprusside (NP) + PE.
First, under control conditions the flow was
increased in progressive steps of 5 ml/min
(5, 10, 15 and 20 ml/min). The same proto-
col was then repeated with hearts perfused
with 0.5 µg/ml PE until systolic pressure
stabilization, which was attained after 10
min. In the third protocol, the PE perfusion
solution was supplemented with 100 mg/ml
NP to induce coronary vasodilatation. This
procedure was used to investigate if the ef-
fects of PE were changed by complete va-
sodilatation.
Phenylephrine, propranolol, atropine,
urethane and nitroprusside were purchased
from Sigma Chemical Co., St. Louis, MO.
Statistical analysis
Data are reported as means ± SEM. Re-
peated measures ANOVA was used to com-
pare means among groups. When the results
of ANOVA were significant, the Tukey test
was used to compare means. Statistical sig-
nificance was set at P<0.05.
Results
In vivo experiments
In this protocol the effects of α1-adreno-
ceptor stimulation were studied in anesthe-
tized rats before and after ß-adrenergic and
cholinergic blockade. Table 1 shows that
anesthetized rats increased their LVSP in
response to phenylephrine administration,
and changes in MAP were similar to those
observed for LVSP, showing increases of 17
± 2.39 mmHg. Phenylephrine produced a
small nonsignificant increase of dP/dt. To
avoid the influence of autonomic reflexes
resulting from α1-adrenoceptor stimulation,
propranolol plus atropine were administered
to achieve a ß-adrenergic and cholinergic
blockade. The protocol was repeated after
20 min and LVSP was reduced. PE adminis-
tration produced an increase of LVSP which
was not followed by dP/dt increments, while
MAP increased 23.8 ± 2.4 mmHg.
In vitro experiments
Figure 1 shows the relationship between
increases of flow and CPP and between flow
and ISP. A significant positive linear corre-
lation between flow and CPP was obtained
(R = 0.88, P<0.0001) as expected, since in
this preparation CCP is directly related to
flow and vascular coronary resistance. A
positive linear correlation was also observed
between ISP and flow (R = 0.51, P<0.001),
suggesting interdependence between these
two variables (Figure 1).
To evaluate the dependence of the effects
of α1-adrenergic stimulation during flow in-
creases the preparations were perfused with
Table 1 - Effects of phenylephrine (PE) on left ventricular systolic pressure (LVSP) and
rate of rise of pressure (dP/dt) in anesthetized rats before and after sympathetic and
parasympathetic blockade with propranolol and atropine.
Results are reported as means ± SEM. *P<0.05 vs each respective control value (two-
way ANOVA).
Before blockade After blockade
Control PE Control PE
LVSP 113 ± 7.44 126 ± 5.6* 89.5 ± 5.66 107 ± 1.22*
(mmHg)
dP/dt 1635 ± 213 1657 ± 274 1370 ± 144 1428 ± 192
(mmHg/s)
1356
Braz J Med Biol Res 31(10) 1998
P.F. Vassallo et al.
PE and the flow was then increased in steps
according to the proposed protocol. A simi-
lar relationship between flow increment and
CPP was obtained (Figure 2, upper panel).
The same protocol was repeated perfusing
the preparations with PE and NP and again
similar results were obtained (Figure 2, up-
per panel).
When the correlation of coronary flow
increments with ISP was determined (Figure
2, lower panel), the existence of a flow-
dependent ISP increase was observed. How-
ever, during PE infusion ISP increased, dis-
placing upwards the flow vs ISP curve. The
infusion of PE + NP produced an additional
increment of ISP values, again displacing
upwards the flow vs ISP curve (Figure 2,
lower panel).
Since the volume of the intraventricular
balloon was maintained constant during these
interventions, the effects of increasing coro-
nary flow on ventricular diastolic pressure
were analyzed. Although significant, only
small increases of diastolic pressure were
observed (Figure 3). It is interesting to note
that as the coronary flow increased, left ven-
tricular diastolic pressure (LVDP) also in-
creased in controls and PE + NP perfused
hearts. Preparations perfused only with PE
did not show changes in LVDP with increas-
ing flow.
Discussion
In the present study we report evidence
that during α1-adrenergic stimulation the
mechanical performance may increase as the
result of two factors simultaneously: a) di-
rect α1-adrenergic stimulation of the myo-
cardium and b) increased coronary perfu-
sion pressure produced by the higher arterial
blood pressure consequent to vasoconstric-
tion.
Several investigators have described a
positive inotropic effect produced by an in-
crease in coronary perfusion pressure (1,2,
4,5). The putative mechanisms responsible
for this positive inotropic effect were re-
ported to be an increase of flow in excess of
metabolic demands (2), sarcomere stretch-
ing as the result of distended vessels (7), a
direct effect of pressure increasing intracel-
lular calcium (14), and also as the result of
changes in ionic composition or volume of
the interstitium and an inotropic factor pro-
duced by the endothelium or intramyocardial
neurons (6).
Under physiological conditions, a pos-
sible mechanism that increases coronary
blood flow is an increase of perfusion pres-
sure (5). Increasing peripheral vascular re-
sistance can achieve this, for instance with
α1-adrenergic stimulation, which, in turn,
increases aortic pressure and CPP. In paral-
lel, α1-adrenergic stimulation also increases
force development. This effect is not medi-
ated by increasing transmembrane Ca2+ in-
flux but by increasing the intracellular con-
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Figure 1 - Effects of increases of
coronary flow on coronary perfu-
sion pressure (CPP) and isovol-
umic systolic pressure (ISP) of
Langendorff-perfused hearts un-
der control conditions. Each
point indicates the mean ± SEM
(N = 7). *P<0.01 vs the smaller
flow (one-way repeated meas-
ures ANOVA).
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centration of inositol (1,4,5)-trisphosphate
(IP3) (9-11). This seems to be achieved by
activation of a phospholipase C that acts on
phosphatidylinositol 4,5-biphosphate (PIP2)
forming IP3 and diacylglycerol (DAG). IP3
in turn activates sarcoplasmic reticulum Ca2+
channels increasing myoplasmic Ca2+ con-
centration (11,12).
Therefore, increased myocardial contrac-
tion may be obtained not only by the direct
α1-adrenergic action on the myocardium but
also by the increase in coronary perfusion
pressure and flow resulting from a higher
arterial blood pressure. We then investigated
the contribution of each factor to the in-
crease in myocardial contraction that occurs
during α1-sympathetic stimulation.
The first protocol was used to investigate
the α1-adrenergic stimulation produced by
PE administration. This was done before and
after simultaneous ß-adrenergic and cholin-
ergic blockade since it is necessary to take
into consideration that the existence of op-
erational reflex mechanisms may superim-
pose or blunt this α1-adrenergic stimulation
in vivo. The results showed that α1-adrener-
gic effects alone produced changes in LVSP
and MAP both before and after the double
blockade, but the cardiac inotropic state
evaluated by dP/dt changes was not influ-
enced by α1-adrenergic stimulation. The re-
duction in LVSP after the double blockade
was expected (15). The lack of dP/dt en-
hancement during α1-adrenergic stimulation,
despite an increase in LVSP, is usually found
in vivo (16). Nevertheless, under more con-
trolled conditions using an isolated prepara-
tion, α1-adrenergic stimulation alone in-
creased the rate of force development or
shortening (17). It is clear from these experi-
ments that α-adrenergic stimulation increases
LVSP and MAP. However, this increase in
LVSP could be the result of a direct α1-
adrenergic effect on the myocardium or the
result of an increased coronary flow pro-
duced by the increased arterial blood pres-
sure.
In vivo α1-adrenergic stimulation in-
creases systolic pressure by a direct myocar-
dial effect and increases vascular resistance.
The result is an increase of MAP and conse-
quently of aortic pressure that increases CPP.
We used Langendorff-perfused rat hearts to
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Figure 2 - Upper panel, Effects
of increases of coronary flow on
the coronary perfusion pressure
(CPP) obtained under control
conditions (Cont), during phen-
ylephrine (PE) perfusion and dur-
ing simultaneous perfusion of
PE plus nitroprusside (NP).
Lower panel, Effects of in-
creases of coronary flow on the
isovolumic systolic pressure
(ISP) obtained under control con-
ditions (Cont), during PE perfu-
sion and during simultaneous
perfusion of PE plus NP. Each
point indicates the mean ± SEM
(N = 7). *P<0.01 for PE or PE +
NP vs the control condition at
each flow. +P<0.01 for compari-
sons between PE and PE + NP
at each flow (two-way repeated
measures ANOVA). Observe
that CPP, although increasing as
a function of flow increment, did
not change with PE or PE + NP
treatments.
Figure 3 - Effects of increases of
coronary flow on left ventricular
diastolic pressure (LVDP) during
phenylephrine (PE) perfusion
and during simultaneous perfu-
sion of PE plus nitroprusside
(NP). Each point indicates the
mean ± SEM (N = 7). *P<0.01
for PE or PE + NP vs control
condition at each flow (repeated
measures ANOVA).
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evaluate the relative contributions of each
factor, the increase in coronary flow pro-
duced by the increase in CPP and the myo-
cardial α1-adrenergic stimulation.
The hearts were perfused at a constant
flow since with this method perfusion pres-
sure changes as a function of flow and vas-
cular resistance. We chose to work with
increasing flow rates because they simulta-
neously produced an increase in perfusion
pressure. The relationship between flow and
CPP obtained under control conditions and
during PE or PE + NP perfusion was similar,
suggesting that the changes in coronary vas-
cular resistance were not demonstrable in
the presence of the effects of the drugs.
The results indicate that the increase in
coronary flow and perfusion pressure did
increase ISP, in agreement with previous
reports (1,2,5). The hearts were then per-
fused with PE, an α1-adrenergic agonist. It
could be seen that LVSP was increased at all
flow rates used, as suggested by the upward
displacement of the pressure-flow curves.
This indicates that an additional increase of
pressure development was obtained, although
the same relationship between pressure and
flow was maintained. Since α1-adrenocep-
tor stimulation may produce coronary vaso-
constriction (16) NP was used to fully dilate
the vessels. On the basis of these findings,
we conclude that, in addition to the ISP
increase produced by increasing coronary
flow, PE infusion produced an additional
increase of ISP. This effect was increased by
NP infusion, which produced an extra ISP
increase. This would suggest that vasocon-
striction could be limiting the availability of
O2. However, the existence of a similar CPP
vs coronary flow relationship in the 3 condi-
tions studied suggested that this is unlikely.
The extra ISP increase could be explained by
a small edema development as suggested by
Rubboli et al. (18). In our preparations iso-
lated hearts were perfused at 31oC and the
solution was thoroughly filtered (0.8-µm fil-
ter) in order to reduce the increase in CPP
during the course of the experiments (19).
Nevertheless, a small increase in CPP and
consequently ISP could be explained by
edema formation (18). This view was sup-
ported by the fact that in our preparations the
DP increased more during PE + NP infusion.
In conclusion, our data suggest that both
mechanisms, i.e., α1-adrenoceptor stimula-
tion and the flow increase produced by the
higher arterial blood pressure consequent to
peripheral vasoconstriction, can increase
cardiac performance by acting simulta-
neously and synergistically.
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